Home › Colite ulcerosa › North Carolina
Studi clinici su Colite ulcerosa nello stato di North Carolina
24 studi su Colite ulcerosa cercano partecipanti presso sedi nello stato di North Carolina.
Città nello stato di North Carolina
Testo ufficiale dello studio (inglese)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Partners /ID# 280490, Asheville
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte
- Carolina Digestive Diseases, Greenville
- Piedmont Healthcare, Statesville
- e altri 1
In reclutamentoFase 4
Età da 18 a 80 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06581328Confirmatory Clinical Study in Active Ulcerative Colitis
- Cross Creek Medical Clinic, Fayetteville
- Peters Medical Research, High Point
In reclutamentoFase 2
Età 16 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Raleigh
In reclutamentoFase 1/2Volontari sani benvenuti
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- 040, Chapel Hill
- Site 041, Durham
- Site 016, Winston-Salem
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07012395A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Monroe Biomedical Research, Monroe
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Coastal Research Institute - Fayetteville, Fayetteville
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Carolina Digestive Diseases and Endoscopy Center, Greenville
- Wilmington Health, PLLC, Wilmington
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Digestive Health Partners, Asheville
- University of North Carolina, Chapel Hill
In reclutamentoFase 4
Età da 18 a 65 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Cross Creek Medical Clinic - Site Number: 8400057, Fayetteville
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07185009A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
In reclutamentoFase 4
Età 18 e oltre · Donne · Aggiornato il 28 ago 2026 · NCT07654751A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Atrium Health Gastroenterology and Hepatology, Charlotte
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- UNC Hospitals, The University of North Carolina at Chapel Hill - Site Number: 8400074, Chapel Hill
- OnSite Clinical Solutions - Site Number: 8400051, Charlotte
- Duke University Medical Center - Site Number: 8400093, Durham
- e altri 3
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- UNC Chapel Hill, Chapel Hill
In reclutamento
Età da 18 a 85 · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of North Carolina, Chapel Hill
- Atrium Health Center for Gastroenterology and Surgery, Charlotte
- Wake Forest School of Medicine, Winston-Salem
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ago 2026 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill
- OnSite Clinical Solutions, LLC, Charlotte
In reclutamentoStudio osservazionale
Età da 18 a 64 · Tutti i sessi · Aggiornato il 9 lug 2026 · NCT06398626A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
- PPD Virtual - PPD - US, Wilmington
In reclutamentoStudio osservazionale
Tutte le età · Donne · Aggiornato il 15 giu 2026 · NCT05953402A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400002, Chapel Hill
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 23 apr 2026 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, High Point
- Mirador Therapeutics Selected Site, Raleigh
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT07113522Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 010, Greenville
In reclutamentoFase 4
Età da 5 a 17 · Tutti i sessi · Aggiornato il 16 set 2025 · NCT04314375Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of North Carolina, Chapel Hill
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 mag 2025 · NCT06750731IBD Pregnancy Registry
- PPD, Wilmington
In reclutamentoStudio osservazionale
Età da 18 a 50 · Donne · Aggiornato il 4 apr 2025 · NCT06910553Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.